S&P 500
7,757.17
+44.60
+0.58%
Dow
52,856.09
+360.19
+0.69%
Nasdaq
26,702.86
+278.04
+1.05%
NYSE Composite
24,253.12
+62.52
+0.26%
Russell 2000
2,781.02
+7.60
+0.27%
VIX
16.68
-0.63
-3.64%
TRLV · Trulieve Cannabis Corp.
NEW YORK STOCK EXCHANGE, INC. - BOATS Real Time Price • USD
Trulieve Cannabis Corp (TRLV)
NEW YORK STOCK EXCHANGE, INC.
Pharmaceuticals
$10.98
+0.21
(+1.95%)
● At close: October 21 at 4:00:00 PM EDT
DAY'S RANGE
$10.98
$10.86
$11.55
52-WEEK RANGE
$10.98
$7.82
$12.93
What's happening
- TRLV is up 1.95% today, trading at $10.98. — Live quote
- Volume today (74,746) is well below its 3-month average of 1,656,090. (Finnhub fundamentals)
- Reports earnings on 2026-11-05, 14 days away. (Finnhub earnings calendar)
- Last quarter's EPS missed estimates: $-2.10 actual vs. $0.06 estimated (-3386.4%). (Finnhub earnings history)
Deterministic template sentences filled in from the same sourced figures shown elsewhere on this page -- not an AI-written summary, no live model call.
Key Statistics
Analyst Recommendations
Strong buy 2
Buy 10
Hold 1
Sell 0
Strong sell 0
Aggregate ratings for 2026-10-01 (13 analysts polled by Finnhub) — consensus count.
Performance Overview (Trailing returns vs S&P 500 benchmark)
YTD RETURN
TRLV
-6.17%
vs S&P 500
-12.19%
3-MONTH RETURN
TRLV
+20.42%
Earnings Trends (Quarterly EPS Actual vs Estimate)
2026-07-26 (Q2 2026)
$-2.10
Est. $0.06
MISS -3386.4%
2026-04-26 (Q1 2026)
$0.01
Est. $-0.02
BEAT +165.4%
2026-01-26 (Q4 2025)
$-0.23
Est. $-0.02
MISS -866.4%
2025-10-26 (Q3 2025)
$-0.14
Est. $-0.09
MISS -52.5%
Valuation Measures & Ratios
Enterprise Value4$2.27B
Forward P/E5—
PEG Ratio6-0.02
Price / Sales (TTM1)1.86
Price / Book72.46
EV4 / Revenue—
EV4 / EBITDA—
Profit Margin-41.55%
Operating Margin-24.49%
Return on Equity (ROE8)-44.03%
Return on Assets (ROA9)-18.04%
Avg Volume (3M)1,656,090
Glossary — what these abbreviations mean
- 1. TTM
- Trailing twelve months — the sum of the last four reported quarters, not a calendar year or the single latest quarter.
- 2. EPS
- Earnings per share — net income divided by diluted shares outstanding.
- 3. Beta
- A stock's historical volatility relative to the overall market. Above 1 means it has moved more than the market; below 1, less.
- 4. EV (Enterprise Value)
- Market cap plus total debt minus cash — roughly what it would cost to buy the whole company, debt included.
- 5. Forward P/E
- Price divided by analysts' estimated earnings for the next 12 months, instead of trailing actual earnings.
- 6. PEG Ratio
- P/E divided by expected earnings growth rate. A lower number can indicate a stock is cheap relative to how fast it's expected to grow.
- 7. Price / Book
- Share price divided by book value (assets minus liabilities) per share.
- 8. ROE
- Return on equity — net income divided by shareholders' equity, a measure of how efficiently a company turns equity into profit.
- 9. ROA
- Return on assets — net income divided by total assets, a measure of how efficiently a company turns assets into profit.
- 10. MRQ
- Most recent quarter — the single latest reported period, as opposed to TTM. The Financials section's "Quarterly" view below shows MRQ-style figures.
- 11. YoY
- Year over year — percent change versus the same period one year earlier, used for growth figures like those on Compare cards and the Screener.
Short Interest
Shares Short6,435,718
Change from Prior Settlement+25.77%
% of Float—
Days to Cover (Short Ratio)1.86
Source: FINRA Rule 4560 consolidated short interest, settlement date 2026-09-30. Reported bi-monthly with a reporting lag — not real-time.
Quotes and the 1-day extended-hours chart: Yahoo Finance. Longer historical charts: Alpaca (IEX feed) — real-time but IEX-only volume (~2.5% of consolidated market volume). Fundamentals + earnings: Finnhub.
Price history
Events
Drag horizontally to zoom into a section; use Reset view to restore all observations.
Technical signal summary
Calculating from the latest year of daily price history…
Show Technical Analysis Breakdown ▾ 10 Indicators
Not investment advice — read several signals together.
Indicators None active
Loading chart…
History limited by data provider; markers are heuristics, not signals.
Peer and sector context
No reviewed peer group is available for this symbol.
Balanced evidence
A deterministic summary of sourced facts—not an AI verdict.
Potential strengths
- Latest SEC filing is Form 8-K, filed 2026-08-11; review it for current changes and risks. SEC EDGAR ↗
Potential concerns
- Revenue growth is -10.3% on the provider's reported measure. Finnhub fundamentals ↗
- Net profit margin is -41.5%. Finnhub fundamentals ↗
Rule-based facts only; absence from either side is not evidence, and this is not a recommendation.
More on TRLV
No accessible free API for these — links go to the source directly.
Financials
Fundamental trends
Visualized from the same SEC figures in the tables below.
Income statement
| Line item | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 | Sep '24 | Jun '24 | Mar '24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $271.0M | $286.8M | $288.2M | $302.1M | $297.8M | $284.3M | $303.4M | $297.6M |
| Gross profit | $162.3M | $170.1M | $169.9M | $182.9M | $183.2M | $173.3M | $181.6M | $173.8M |
| Operating income | -$370.5M | $35.7M | $42.2M | $52.6M | $33.3M | $618.0K | $49.8M | $46.1M |
| Net income | — | — | — | — | — | -$61.6M | -$12.0M | -$24.5M |
| EPS (diluted) | — | — | — | — | $-0.16 | $-0.32 | $-0.04 | $-0.16 |
| EPS (basic) | — | — | — | — | $-0.16 | $-0.32 | $-0.04 | $-0.16 |
| Operating margin | -$137 | $12 | $15 | $17 | $11 | $0 | $16 | $15 |
| Net margin | — | — | — | — | — | -$22 | -$4 | -$8 |
Balance sheet
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $2.08B | $2.78B | $2.70B | $2.94B | $2.92B | $2.89B | $2.87B | $2.87B |
| Total liabilities | $1.31B | $1.63B | $1.55B | $1.76B | $1.71B | $1.67B | $1.62B | $1.57B |
| Stockholders' equity | — | — | — | — | — | — | — | — |
| Total current assets | $564.8M | $653.0M | $562.7M | $756.4M | $711.4M | $649.4M | $604.6M | $603.0M |
| Total current liabilities | $95.1M | $124.2M | $126.9M | $124.1M | $123.8M | $136.7M | $138.5M | $136.7M |
| Cash & equivalents | $325.4M | $352.9M | $255.5M | $449.2M | $392.6M | $328.5M | $238.8M | $237.7M |
| Marketable securities (current) | — | — | $0 | $0 | $0 | $0 | $60.4M | $80.2M |
| Accounts receivable | $3.9M | $14.1M | $10.5M | $10.5M | $10.8M | $10.3M | $8.3M | $9.0M |
| Inventory | $186.9M | $242.3M | $242.3M | $243.3M | $241.5M | $239.3M | $231.4M | $220.9M |
| Other current assets | $4.7M | $13.7M | $25.5M | $22.1M | $24.5M | $32.3M | $26.2M | $26.6M |
| Property, plant & equipment | $584.0M | $676.9M | $670.4M | $694.0M | $699.0M | $710.1M | $716.1M | $701.6M |
| Goodwill | $325.6M | $483.9M | $483.9M | $483.9M | $483.9M | $483.9M | $483.9M | $483.9M |
| Intangible assets | $300.4M | $780.8M | $798.4M | $815.3M | $832.4M | $848.8M | $859.5M | $873.3M |
| Other non-current assets | $8.7M | $10.0M | $10.0M | $10.4M | $10.6M | $11.5M | $19.8M | $23.0M |
| Accounts payable | — | — | $26.8M | — | — | — | $20.2M | — |
| Deferred revenue (current) | $7.0M | $10.0M | $9.6M | $8.9M | $8.4M | $8.7M | $8.0M | $6.7M |
| Short-term debt | — | — | — | — | — | — | — | — |
| Long-term debt | $195.8M | $195.6M | $136.7M | $366.1M | $365.7M | $365.3M | $364.8M | $364.4M |
| Other non-current liabilities | $10.0M | $10.8M | $11.4M | $11.8M | $11.9M | $5.5M | $5.0M | $6.5M |
| Common stock & paid-in capital | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Retained earnings | -$1.32B | -$909.7M | -$912.1M | -$869.2M | -$842.4M | -$828.6M | -$795.7M | -$736.0M |
Cash flow
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $53.1M | $55.7M | $59.2M | $76.4M | $86.1M | $51.1M | $30.7M | $30.3M |
| Investing cash flow | -$74.9M | -$13.2M | -$5.9M | -$15.0M | -$8.6M | $43.0M | -$23.2M | -$131.5M |
| Financing cash flow | -$5.7M | $54.8M | -$255.4M | -$4.8M | -$5.8M | -$4.5M | -$6.4M | -$16.4M |
| Free cash flow | — | — | $55.8M | $64.1M | $74.5M | $34.2M | -$12.0M | -$7.8M |
| Capital expenditures | — | — | $3.4M | $12.3M | $11.6M | $16.9M | $42.7M | $38.1M |
| Share-based compensation | $6.9M | $4.1M | $4.0M | $5.8M | $6.8M | $3.9M | $4.6M | $5.5M |
| Deferred income taxes | -$10.8M | -$8.2M | -$3.2M | -$4.7M | -$5.3M | -$4.7M | -$7.7M | -$6.2M |
| Change in accounts receivable | -$1.1M | $3.9M | $328.0K | $28.0K | $762.0K | $2.6M | -$1.5M | $1.5M |
| Change in inventory | -$6.0M | $22.0K | -$992.0K | $1.8M | $2.2M | $7.9M | $10.5M | $13.3M |
| Debt issued | $0 | $60.7M | — | — | $0 | $0 | — | — |
| Tax withholding on stock comp | $1.3M | $0 | $4.4M | $196.0K | $57.0K | $238.0K | $2.5M | $12.2M |
Income statement
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Revenue | $1.18B | $1.19B | $1.13B | $1.22B | $931.9M |
| Gross profit | $711.2M | $715.7M | $588.6M | $689.1M | $566.6M |
| Operating income | $143.5M | $97.8M | -$221.6M | $50.2M | $204.1M |
| Net income | — | — | — | -$252.7M | $17.4M |
| EPS (diluted) | $-0.58 | $-0.79 | $-2.28 | $-0.95 | $0.21 |
| EPS (basic) | $-0.58 | $-0.79 | $-2.28 | $-0.95 | $0.22 |
| Operating margin | $12 | $8 | -$20 | $4 | $22 |
| Net margin | — | — | — | -$21 | $2 |
Balance sheet
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Total assets | $2.70B | $2.87B | $2.73B | $3.40B | $3.41B |
| Total liabilities | $1.55B | $1.62B | $1.32B | $1.47B | $1.26B |
| Total current assets | $562.7M | $604.6M | $477.3M | $593.5M | $524.9M |
| Total current liabilities | $126.9M | $138.5M | $114.8M | $210.3M | $169.4M |
| Cash & equivalents | $255.5M | $238.8M | $201.4M | $207.2M | $226.6M |
| Marketable securities (current) | $0 | $60.4M | $0 | — | — |
| Accounts receivable | $10.5M | $8.3M | $6.7M | $6.5M | $8.6M |
| Inventory | $242.3M | $231.4M | $213.1M | $276.5M | $209.9M |
| Other current assets | $25.5M | $26.2M | $23.7M | $51.2M | $12.2M |
| Property, plant & equipment | $670.4M | $716.1M | $676.4M | $743.3M | $779.4M |
| Goodwill | $483.9M | $483.9M | $483.9M | $791.5M | $765.4M |
| Intangible assets | $798.4M | $859.5M | $917.2M | $984.8M | $1.08B |
| Other non-current assets | $10.0M | $19.8M | $10.4M | $12.8M | $17.6M |
| Accounts payable | $26.8M | $20.2M | $28.2M | $15.9M | $14.3M |
| Deferred revenue (current) | $9.6M | $8.0M | $1.3M | — | — |
| Long-term debt | $136.7M | $364.8M | $363.2M | $541.7M | $462.9M |
| Other non-current liabilities | $11.4M | $5.0M | $7.1M | $6.8M | $8.4M |
| Common stock & paid-in capital | $0 | $0 | $0 | $0 | — |
| Retained earnings | -$912.1M | -$795.7M | -$640.6M | -$113.8M | $137.7M |
Cash flow
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Operating cash flow | $272.8M | $271.5M | $201.8M | $23.1M | $12.9M |
| Investing cash flow | $13.5M | -$206.6M | -$37.5M | -$215.1M | -$215.2M |
| Financing cash flow | -$270.5M | -$33.4M | -$175.6M | $177.8M | $289.2M |
| Free cash flow | $228.6M | $148.9M | $161.6M | -$141.7M | -$263.0M |
| Capital expenditures | $44.2M | $122.6M | $40.2M | $164.7M | $275.9M |
| Share-based compensation | $20.5M | $20.2M | $10.6M | $18.1M | $9.3M |
| Deferred income taxes | -$17.8M | -$10.4M | -$17.2M | -$27.2M | -$26.3M |
| Change in accounts receivable | $3.7M | -$741.0K | $1.7M | $4.2M | $4.9M |
| Change in inventory | $10.9M | $18.7M | -$83.3M | $83.4M | $19.6M |
| Tax withholding on stock comp | $4.8M | $14.8M | $466.0K | $615.0K | $1.1M |
Source: SEC EDGAR XBRL filings (10-Q/10-K), as originally tagged by the company. Quarterly cash flow is reconstructed by de-cumulating fiscal-year-to-date figures (how cash flow is tagged in 10-Qs); other quarterly lines are reported directly.
Institutional holders
SEC Form 13F filers holding TRLV as of the latest reported quarter. 13F only covers investment managers with $100M+ in assets — this is not a complete ownership picture, and does not include insiders (see Recent SEC filings below) or non-13F-eligible holders.
Source: Business Quant SEC Form 13F · report period 2026-06-30 · 32 filers
Held by These Filers17.6%
Shares Outstanding192,714,241
| Filer | Shares | Value | % Out | Qtr Change | Filed |
|---|---|---|---|---|---|
| AdvisorShares Investments LLC | 10,641,152 | $104.6M | 5.52% | +0.0% | 2026-08-11 |
| Nomura Holdings Inc | 5,065,849 | $49.8M | 2.63% | +0.0% | 2026-08-14 |
| CANTOR FITZGERALD, L. P. | 3,750,000 | $36.9M | 1.95% | +0.0% | 2026-08-14 |
| Marex Group Ltd | 3,250,000 | $31.9M | 1.69% | +0.0% | 2026-08-14 |
| Ing Groep Nv | 2,665,000 | $26.2M | 1.38% | +0.0% | 2026-08-13 |
| OAKMONT Corp | 1,506,511 | $1.1M | 0.78% | +0.0% | 2026-08-06 |
| JANE STREET GROUP, LLC | 1,212,526 | $11.9M | 0.63% | +0.0% | 2026-08-14 |
| PICTON MAHONEY ASSET MANAGEMENT | 838,088 | $8.2M | 0.43% | +0.0% | 2026-08-13 |
| Anson Funds Management LP | 524,500 | $5.6M | 0.27% | +0.0% | 2026-08-13 |
| iA Global Asset Management Inc. | 522,992 | $5.1K | 0.27% | +0.0% | 2026-07-29 |
| Verition Fund Management LLC | 500,000 | $4.9M | 0.26% | +0.0% | 2026-08-14 |
| MONTANOVA CAPITAL, LLC | 356,100 | $3.5M | 0.18% | +0.0% | 2026-08-14 |
| Murchinson Ltd. | 355,200 | $3.5M | 0.18% | +0.0% | 2026-08-13 |
| Purpose Unlimited Inc. | 342,560 | $3.4M | 0.18% | +0.0% | 2026-07-24 |
| Cresset Asset Management, LLC | 284,488 | $2.8M | 0.15% | +0.0% | 2026-08-14 |
| Proficio Capital Partners LLC | 201,931 | $2.0M | 0.10% | +0.0% | 2026-08-14 |
| Manatuck Hill Partners, LLC | 200,000 | $2.0M | 0.10% | +0.0% | 2026-08-14 |
| NewGen Asset Management Ltd | 200,000 | $2.0M | 0.10% | +0.0% | 2026-08-13 |
| HighTower Advisors, LLC | 156,492 | $1.5M | 0.08% | +0.0% | 2026-08-05 |
| OLD MISSION CAPITAL LLC | 149,391 | $1.5M | 0.08% | +0.0% | 2026-08-07 |
| Virtu Financial LLC | 149,016 | $1.5K | 0.08% | +0.0% | 2026-08-12 |
| FORMULA GROWTH LTD | 120,000 | $1.2M | 0.06% | +0.0% | 2026-08-14 |
| NANO CAP NEW MILLENNIUM GROWTH FUND L P | 120,000 | $1.2M | 0.06% | -17.2% | 2026-08-14 |
| Corient Private Wealth LP | 117,132 | $1.2M | 0.06% | +0.0% | 2026-08-12 |
| BlueChip Wealth Advisors LLC | 114,464 | $1.1M | 0.06% | +0.0% | 2026-07-30 |
Insider activity
Directors, officers, and 10%+ owners' reported transactions from SEC Form 4. A filing reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR Form 4 filings · checked 25 most recent filings · covers 2025-12-01 to 2026-06-26
Recent transactions
- Insiders have net sold 1,699,007 shares over the last 182 days, across 0 purchases and 7 sales.
- Most recent: Rivers Kim A. (Chairman and CEO) — Open market sale of 136,811 shares on 2026-06-26.
Deterministic template sentences filled in from the SEC Form 4 figures in the tables below -- not an AI-written summary, no live model call.
Insider purchases & sales, last 6 months
Purchases (open market)0 sh(0 txns)
Sales (open market)1,699,007 sh(7 txns)
Net Shares-1,699,007
Counts only open-market purchases (code P) and sales (code S) — grants, option exercises, tax withholding, and gifts are excluded since they aren't a market buy/sell decision.
Insider roster
| Name | Title | Most Recent Transaction | Date | Shares |
|---|---|---|---|---|
| Rivers Kim A. | Chairman and CEO | Open market sale | 2026-06-26 | 136,811 |
| Pernell Jason | President | Grant / award | 2026-03-13 | 58,594 |
| Hersey Christine Ann | Chief Corp Affairs & Strategy | Grant / award | 2026-03-13 | 58,594 |
| Landrum Kyle | Chief Production Officer | Grant / award | 2026-03-13 | 58,594 |
| Reese Jan | Chief Financial Officer | Grant / award | 2026-03-13 | 58,594 |
| Powers Eric | Chief Legal Officer | Grant / award | 2026-03-13 | 58,594 |
| Jhala Nilyum | Chief Technology Officer | Grant / award | 2026-03-13 | 58,594 |
| Walsh Brett R. | Chief Accounting Officer | Grant / award | 2026-03-13 | 28,711 |
| Thronson Susan | Director | Grant / award | 2026-03-13 | 23,438 |
| MILLNER THOMAS L | Director | Grant / award | 2026-03-13 | 23,438 |
| Foulston Matthew J. | Director | Grant / award | 2026-03-13 | 23,438 |
| Morreau Jane Cecil | Director | Grant / award | 2026-03-13 | 23,438 |
| May Richard S. | Director | Grant / award | 2026-03-13 | 23,438 |
| Healy Peter | Director | Grant / award | 2026-03-13 | 23,438 |
| Beshears Thad | Director | Grant / award | 2026-03-13 | 23,438 |
| Morey Timothy | Chief Sales Officer | Tax withholding | 2025-12-01 | 16,744 |
| Malivuk Joy | Chief Accounting Officer | Tax withholding | 2025-12-01 | 7,850 |
Recent transactions
| Date | Insider | Title | Transaction | Shares | Price |
|---|---|---|---|---|---|
| 2026-06-26 | Rivers Kim A. | Chairman and CEO | Open market sale | 136,811 | $8.76 |
| 2026-06-25 | Rivers Kim A. | Chairman and CEO | Open market sale | 300,000 | $8.17 |
| 2026-06-24 | Rivers Kim A. | Chairman and CEO | Open market sale | 400,000 | $8.17 |
| 2026-06-23 | Rivers Kim A. | Chairman and CEO | Open market sale | 380,000 | $8.47 |
| 2026-06-22 | Rivers Kim A. | Chairman and CEO | Open market sale | 204,815 | $9.35 |
| 2026-06-18 | Rivers Kim A. | Chairman and CEO | Open market sale | 139,846 | $9.46 |
| 2026-06-17 | Rivers Kim A. | Chairman and CEO | Open market sale | 137,535 | $9.36 |
| 2026-03-13 | Rivers Kim A. | Chairman and CEO | Grant / award | 218,750 | $0.00 |
| 2026-03-13 | Pernell Jason | President | Grant / award | 58,594 | $0.00 |
| 2026-03-13 | Hersey Christine Ann | Chief Corp Affairs & Strategy | Grant / award | 58,594 | $0.00 |
| 2026-03-13 | Landrum Kyle | Chief Production Officer | Grant / award | 58,594 | $0.00 |
| 2026-03-13 | Reese Jan | Chief Financial Officer | Grant / award | 58,594 | $0.00 |
| 2026-03-13 | Powers Eric | Chief Legal Officer | Grant / award | 58,594 | $0.00 |
| 2026-03-13 | Jhala Nilyum | Chief Technology Officer | Grant / award | 58,594 | $0.00 |
| 2026-03-13 | Walsh Brett R. | Chief Accounting Officer | Grant / award | 28,711 | $0.00 |
| 2026-03-13 | Thronson Susan | Director | Grant / award | 23,438 | $0.00 |
| 2026-03-13 | MILLNER THOMAS L | Director | Grant / award | 23,438 | $0.00 |
| 2026-03-13 | Foulston Matthew J. | Director | Grant / award | 23,438 | $0.00 |
| 2026-03-13 | Morreau Jane Cecil | Director | Grant / award | 23,438 | $0.00 |
| 2026-03-13 | May Richard S. | Director | Grant / award | 23,438 | $0.00 |
| 2026-03-13 | Healy Peter | Director | Grant / award | 23,438 | $0.00 |
| 2026-03-13 | Beshears Thad | Director | Grant / award | 23,438 | $0.00 |
| 2026-03-03 | Rivers Kim A. | Chairman and CEO | Derivative conversion | 820,000 | $0.00 |
| 2025-12-01 | Morey Timothy | Chief Sales Officer | Tax withholding | 16,744 | $5.39 |
| 2025-12-01 | Powers Eric | Chief Legal Officer | Tax withholding | 18,206 | $5.39 |
| 2025-12-01 | Jhala Nilyum | Chief Technology Officer | Tax withholding | 18,041 | $5.39 |
| 2025-12-01 | Landrum Kyle | Chief Production Officer | Tax withholding | 18,359 | $5.39 |
| 2025-12-01 | Rivers Kim A. | Chairman and CEO | Tax withholding | 63,237 | $5.39 |
| 2025-12-01 | Malivuk Joy | Chief Accounting Officer | Tax withholding | 7,850 | $5.39 |
| 2025-12-01 | Pernell Jason | President | Tax withholding | 7,009 | $5.39 |
Recent SEC filings
Official company reports and insider transaction filings. Form 4 reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR submissions · updated 2026-10-22 03:45 UTC
| Filed | Form | Report period | Official filing |
|---|---|---|---|
| 2026-08-11 | 8-K | 2026-08-11 | View on SEC.gov → |
| 2026-08-07 | 10-Q | 2026-06-30 | View on SEC.gov → |
| 2026-08-07 | 8-K | 2026-08-07 | View on SEC.gov → |
| 2026-08-05 | 8-K | 2026-08-05 | View on SEC.gov → |
| 2026-07-02 | 8-K | 2026-06-30 | View on SEC.gov → |
| 2026-06-26 | 4 | 2026-06-26 | View on SEC.gov → |
| 2026-06-25 | 4 | 2026-06-23 | View on SEC.gov → |
| 2026-06-22 | 4 | 2026-06-17 | View on SEC.gov → |
| 2026-06-12 | 8-K | 2026-06-11 | View on SEC.gov → |
| 2026-06-11 | 8-K | 2026-06-09 | View on SEC.gov → |
| 2026-06-09 | 8-K | 2026-06-09 | View on SEC.gov → |
| 2026-06-04 | 8-K | 2026-06-03 | View on SEC.gov → |
Recent news
Headlines about TRLV (Trulieve Cannabis Corp.). Links open the publisher — we don’t host full articles.
-
Trulieve Cannabis delivers 69% return after Fair Value signal
Investing.com · 2026-10-21 -
Top Trulieve Cannabis (TRLV) Competitors 2026
MarketBeat · 2026-10-21 -
Trulieve Cannabis (TRLV) Institutional Ownership 2026 $TRLV
MarketBeat · 2026-10-21 -
Trulieve Cannabis Corp (TRLV) Stock Up 5.0% but GF Value Says Ov
GuruFocus · 2026-10-21 -
Trulieve schedules November 5 results as Trulieve Cannabis stock costs EUR 9.17
AD HOC NEWS · 2026-10-20 -
Trulieve repays USD 65 million mortgage: what it means for Trulieve Cannabis stock
AD HOC NEWS · 2026-10-18 -
Mortgage Payoff Might Change The Case For Investing In Trulieve Stock (TRLV)
Simply Wall Street · 2026-10-17 -
3 Great Biotech Stocks To Watch In October 2026
Yahoo · 2026-10-17
No headlines in this category right now — try “All”.